Common use of GENE THERAPY TECHNOLOGY Clause in Contracts

GENE THERAPY TECHNOLOGY. Notwithstanding Section 7.1.1 above, GenVec shall own all inventions and intellectual property made in connection with this Agreement during the term of this Agreement (i) solely by GenVec employees or agents or jointly by employees or agents of Fuso and GenVec that relate to the introduction of genetic material of nucleic acid composition, or a portion thereof, into a vector and/or cell to create a desired effect or identify an unknown effect, including techniques and processes relating to the manufacture, evaluation and use thereof, and methods relating to all of the foregoing, (ii) by either or both of the parties and/or their agents that relate to or are made using materials transferred to Fuso by or on behalf of GenVec, or (iii) by either or both of the parties and/or their agents that relate to or are made using Collaboration Products, * Vector, * Vector, *-TNF Vector or * Vector (collectively, "Gene Therapy Technology"). Fuso hereby assigns to GenVec all its right, title and interest it may otherwise hold in or to such Gene Therapy Technology and any patent applications or patents relating thereto. Fuso shall, at the request of GenVec, execute, and deliver or cause to be delivered, all such consents, documents or further instruments of assignment or transfer, and take or cause to be taken all such actions GenVec reasonably deems necessary or desirable in order for GenVec to obtain the full benefits of the assignment herein.

GENE THERAPY TECHNOLOGY. Notwithstanding Section 7.1.1 above, GenVec shall own all inventions and intellectual property made in connection with this Agreement during the term of this Agreement Term (i) solely by GenVec employees or agents or jointly by employees or agents of Fuso and GenVec that relate to the introduction of genetic material of nucleic acid composition, or a portion thereof, into a vector and/or cell to create a desired effect or identify an unknown effect, including techniques and processes relating to the manufacture, evaluation and use thereof, and methods relating to all of the foregoing, (ii) by either or both of the parties and/or their agents that relate to or are made using materials transferred to Fuso by or on behalf of GenVec, or (iii) by either or both of the parties and/or their agents that relate to or are made using Collaboration Products, * Vector, * Vector, *-TNF Vector or * Vector (collectively, "Gene Therapy Technology"). Fuso hereby assigns to GenVec all its right, title and interest it may otherwise hold in or to such Gene Therapy Technology and any patent applications or patents relating thereto. Fuso shall, at the request of GenVec, execute, and deliver or cause to be delivered, all such consents, documents or further instruments of assignment or transfer, and take or cause to be taken all such actions GenVec reasonably deems necessary or desirable in order for GenVec to obtain the full benefits of the assignment herein.